Holen Sie sich die Stockscreener-App
0.6052
3.94%
-0.0248
Handel nachbörslich:
.62
0.0148
+2.45%
Schlusskurs vom Vortag:
$0.63
Offen:
$0.6376
24-Stunden-Volumen:
11,939
Relative Volume:
0.07
Marktkapitalisierung:
$3.68M
Einnahmen:
$35.52M
Nettoeinkommen (Verlust:
$11.39M
KGV:
-0.00766
EPS:
-78.9878
Netto-Cashflow:
$-26.04M
1W Leistung:
+3.45%
1M Leistung:
-4.44%
6M Leistung:
-38.87%
1J Leistung:
-53.80%
1-Tages-Spanne:
$0.6022
$0.6376
1-Wochen-Bereich:
$0.57
$0.65
52-Wochen-Spanne:
$0.57
$2.79
Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile
Compare RDHL vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RDHL
Redhill Biopharma Ltd Adr
|
0.6052 | 3.80M | 35.52M | 11.39M | -26.04M | -78.99 |
TAK
Takeda Pharmaceutical Co Adr
|
18.24 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.16 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.93 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.17 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
512.88 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-08-31 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-05-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-09-11 | Eingeleitet | BTIG Research | Buy |
| 2019-07-12 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2019-03-12 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2018-01-26 | Eingeleitet | Nomura | Buy |
| 2017-10-06 | Eingeleitet | Seaport Global Securities | Buy |
| 2017-10-04 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-24 | Bestätigt | FBR & Co. | Outperform |
| 2016-07-27 | Bestätigt | FBR Capital | Outperform |
| 2015-09-29 | Eingeleitet | Nomura | Buy |
| 2015-07-29 | Bestätigt | ROTH Capital | Buy |
| 2015-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-15 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Redhill Biopharma Ltd Adr Aktie (RDHL) Neueste Nachrichten
Can RedHill Biopharma (NASDAQ:RDHL) Show Commercial Progress Today? - Kalkine Media
Ebola Cases and Deaths Rapidly MountRedHill Updates on Opaganib Emergency Outbreak Development - Sahm
RedHill Biopharma Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:RDHL) - TradingView
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - Sahm
RedHill Biopharma closes $6 million private placement - Investing.com
RedHill Biopharma closes $6 million private placement By Investing.com - Investing.com South Africa
Form 6K Redhill Biopharma Ltd For: 22 June By Investing.com - Investing.com Nigeria
Form 6K RedHill Biopharma Ltd. For: 22 June By Investing.com - Investing.com South Africa
RedHill Biopharma raises $6M in private placement - Investing.com
RedHill Biopharma raises $6M in private placement By Investing.com - Investing.com South Africa
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
RedHill Biopharma begins Korea enforcement of $10.9M judgment By Investing.com - Investing.com South Africa
RedHill Biopharma begins Korea enforcement of $10.9M judgment - Investing.com
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo - Barchart.com
RDHL News | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms - Sahm
RDHLRedhill Biopharma Ltd ADR Stock Price and Quote - Finviz
Redhill Biopharma stock soars on GLP-1 side effect treatment progress - Investing.com Nigeria
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104Important Step in RHB-204 Development for MAP-related Crohn's Disease - ChartMill
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights - Sahm
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical StudiesNew Data Presented at AACR 2026 - ChartMill
RDHL Stock Price, Quote & Chart | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
Crohn’s Disease Treatment Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight - Barchart.com
RedHill Biopharma receives Nasdaq notice on minimum bid price requirement By Investing.com - Investing.com South Africa
RedHill Biopharma receives Nasdaq notice on minimum bid price requirement - Investing.com India
Adi Frish details equity holdings in RedHill Biopharma (RDHL) Form 3 - Stock Titan
RDHL Earnings History & Surprises | EPS & Revenue Results | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
Joint U.S. Commercialization of RedHill's Talicia® Commences - ChartMill
Joint U.S. Commercialization of RedHill's Talicia Commences - Finviz
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase - The Globe and Mail
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga
RedHill Biopharma regains compliance with Nasdaq listing requirements - Investing.com
RedHill Biopharma increases maximum amount for at-the-market ADS offering - Investing.com
Redhill Biopharma stock jumps after court win against Kukbo By Investing.com - Investing.com Canada
RedHill Biopharma to appeal Nasdaq compliance notice - Investing.com
Redhill Biopharma Ltd. (RDHL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
RedHill Biopharma stock surges after court upholds $10M judgment By Investing.com - Investing.com UK
RDHL: Revenue up 59% and gross profit doubled, but going concern risk persists amid funding shortfall - TradingView
Get insights into the top gainers and losers of Monday's after-hours session. - ChartMill
RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win - Finviz
RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PR Newswire
RDHL: Net loss, cash burn, and loss of key revenue source put RedHill Biopharma's future at risk - TradingView
Redhill Biopharma stock hits 52-week low at $2.47 amid steep annual decline - Investing.com
Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline - Investing.com UK
Redhill Biopharma stock hits 52-week low at $4.79 By Investing.com - Investing.com India
JUNS Stock Quote Price and Forecast - CNN
RDHL: Net loss narrowed on an adjusted basis as cost cuts and pipeline progress offset lower revenues - TradingView
Redhill Biopharma Ltd Share Price ADR Each Representing 1000 Ord Shares SPON - Hargreaves Lansdown
7 Undervalued Pharmaceuticals Stocks for Wednesday, August 07 - AAII
Trading Volume Is Your Friend - StocksToTrade
Curious about the stocks that are showing activity after the closing bell on Tuesday? - ChartMill
Finanzdaten der Redhill Biopharma Ltd Adr-Aktie (RDHL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):